148 related articles for article (PubMed ID: 31126976)
1. Quantifying Microsatellite Mutation Rates from Intestinal Stem Cell Dynamics in Msh2-Deficient Murine Epithelium.
Christopher J; Thorsen AS; Abujudeh S; Lourenço FC; Kemp R; Potter PK; Morrissey E; Hazelwood L; Winton DJ
Genetics; 2019 Jul; 212(3):655-665. PubMed ID: 31126976
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
[TBL] [Abstract][Full Text] [Related]
3. The effects of MSH2 deficiency on spontaneous and radiation-induced mutation rates in the mouse germline.
Burr KL; van Duyn-Goedhart A; Hickenbotham P; Monger K; van Buul PP; Dubrova YE
Mutat Res; 2007 Apr; 617(1-2):147-51. PubMed ID: 17331550
[TBL] [Abstract][Full Text] [Related]
4. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
5. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
Kucherlapati MH; Lee K; Nguyen AA; Clark AB; Hou H; Rosulek A; Li H; Yang K; Fan K; Lipkin M; Bronson RT; Jelicks L; Kunkel TA; Kucherlapati R; Edelmann W
Gastroenterology; 2010 Mar; 138(3):993-1002.e1. PubMed ID: 19931261
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
7. Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.
Kortüm B; Campregher C; Lang M; Khare V; Pinter M; Evstatiev R; Schmid G; Mittlböck M; Scharl T; Kucherlapati MH; Edelmann W; Gasche C
Gut; 2015 Dec; 64(12):1905-12. PubMed ID: 25429050
[TBL] [Abstract][Full Text] [Related]
8. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers.
Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J;
Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137
[TBL] [Abstract][Full Text] [Related]
9. The mismatch repair protein MSH2 is rate limiting for repeat expansion in a fragile X premutation mouse model.
Lokanga RA; Zhao XN; Usdin K
Hum Mutat; 2014 Jan; 35(1):129-36. PubMed ID: 24130133
[TBL] [Abstract][Full Text] [Related]
10. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine.
Toft NJ; Winton DJ; Kelly J; Howard LA; Dekker M; te Riele H; Arends MJ; Wyllie AH; Margison GP; Clarke AR
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3911-5. PubMed ID: 10097137
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters.
Staffa L; Echterdiek F; Nelius N; Benner A; Werft W; Lahrmann B; Grabe N; Schneider M; Tariverdian M; von Knebel Doeberitz M; Bläker H; Kloor M
PLoS One; 2015; 10(3):e0121980. PubMed ID: 25816162
[TBL] [Abstract][Full Text] [Related]
12. Role of Red Meat and Resistant Starch in Promutagenic Adduct Formation, MGMT Repair, Thymic Lymphoma and Intestinal Tumourigenesis in Msh2 -Deficient Mice.
Winter JM; Hu Y; Young GP; Kohonen-Corish MR; Le Leu RK
J Nutrigenet Nutrigenomics; 2014; 7(4-6):299-313. PubMed ID: 26022687
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
14. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
15. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
16. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
[TBL] [Abstract][Full Text] [Related]
18. Role of the Msh2 gene in genome maintenance and development in mouse fetuses.
He D; Chen Y; Li H; Furuya M; Ikehata H; Uehara Y; Komura J; Mak TW; Ono T
Mutat Res; 2012 Jun; 734(1-2):50-5. PubMed ID: 22465156
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite Instability in Mouse Models of Colorectal Cancer.
Currey N; Daniel JJ; Mladenova DN; Dahlstrom JE; Kohonen-Corish MRJ
Can J Gastroenterol Hepatol; 2018; 2018():6152928. PubMed ID: 29686976
[TBL] [Abstract][Full Text] [Related]
20. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
